Mylan NV (MYL)

MYL (NASDAQ:Drugs) EQUITY
$36.50
pos +0.44
+1.20%
Today's Range: 36.07 - 37.15 | MYL Avg Daily Volume: 6,770,500
Last Update: 12/09/16 - 2:29 PM EST
Volume: 4,590,577
YTD Performance: -33.31%
Open: $36.08
Previous Close: $36.06
52 Week Range: $37.59 - $67.34
Oustanding Shares: 535,105,253
Market Cap: 18,461,131,228
6-Month Chart
TheStreet Ratings Grade for MYL
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 4 3
Moderate Buy 0 0 0 0
Hold 5 5 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.83 1.83 2.20 2.33
Latest Dividend: 0.00
Latest Dividend Yield: 0.54%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 69.00
Price Earnings Comparisons:
MYL Sector Avg. S&P 500
69.00 20.20 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-11.12% -29.65% -18.31%
GROWTH 12 Mo 3 Yr CAGR
Revenue 22.10 0.40 0.11
Net Income -9.20 0.30 0.10
EPS -27.00 0.20 0.05
Earnings for MYL:
EBITDA 2.40B
Revenue 9.43B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $1.42 $1.11 $4.75 $5.35
Number of Analysts 7 2 7 8
High Estimate $1.47 $1.22 $4.80 $5.50
Low Estimate $1.38 $0.99 $4.70 $5.09
Prior Year $1.22 $0.76 $4.30 $4.75
Growth Rate (Year over Year) 16.04% 45.39% 10.37% 12.68%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
The sector excelled right after the election, but lately has been sitting this rally out.
The stock remains pointed down with few signs of encouragement for bulls.
Small-caps could also benefit from abating tax-loss selling.
Famed short-seller says drugmaker at risk of a government crackdown.
As we all know, the stock market and the economy abhor uncertainty.

My Takeaways and Observations Real Money Pro($)

The U.S. dollar strengthened meaningfully. Any more strength will begin to raise concerns about multinational profits. The price of crude oil expanded by $0.80 to nearly $45/barrel. But, we are still in a short term downtrend. Gold fell be $23. I rebuilt my GLD position on the weakness. We are near the 200 day moving average. Ag commodities: wheat down $0.04, corn down $0.02, soybeans up $0.08 and oats are flat. Fertilizer stocks traded well today. Lumber up $1. Bonds got schmeissed. iShares Barclays 20+ Yr Treas.Bond ETF (TLT) down a beaner. The 10-year U.S. note yield rose by four basis points and the long bond by three basis points. The 2s/10s spread widened by two basis points to 101 basis points. Municipals were surprisingly weaker. Closed end muni bond funds flatlined. But high yield was much stronger iShares iBoxx $ High Yid Corp Bond ETF (HYG) +$1 and SPDR Barclays Capital High Yield Bnd ETF (JNK) +$0.40. Blackstone/GSO Strategic Credit Fund (BGB) +$0.13. Banks benefited from the steepening yield curve. I shorted JPMorgan Chase (JPM) , Citigroup (C) and Financial Select Sector SPDR Fund (XLF) late in the day. Insurance stocks were terrific. Long Hartford Financial (HIG) (large) looks like it might be breaking out. (I still owe you guys an analysis of the good quarter release from last week -- coming soon! Small shorts in Lincoln National (LNC) and Metlife (MET) , rose. Brokerages Morgan Stanley (MS) and Goldman Sachs (GS) were the "world's fair." Autos advanced. I remain short (small) General Motors (GM) and Ford (F) . Retail rebounded. My only long JC Penney (JCP) was punk (up a dime after being up three times that amount earlier in the day). Biotech was +3.5%. Allergan (AGN) , Celgene (CELG) ++ Speculative biotech (Portola Pharmaceuticals (PTLA)  , SAGE Therapeutics (SAGE) , Aerie Pharmaceuticals (AERI) ,  Nektar Therapeutics (NKTR
Thursday felt a lot like capitulation in this space. I was buying.
The U.S. dollar strengthened. The price of crude oil continued to roll over: down $0.66 to $44.68. Ag commodities: wheat down $0.05, corn up $0.02, soybeans up $0.03 and oats down $0.04. Lumber up $5. Bonds got schmeissed (iShares Barclays 20+ Yr Treas.Bond ETF (TLT) down a beaner) after staging a two-day recovery. The 10-year U.S. Treasury rose by 2 basis points in yield while the long bond advanced by 4 basis points. The 2s/10s spread rose back to 100 bps. Municipals were flat to higher. Junk bond prices edged a bit higher as well. Blackstone/GSO Strategic Credit Fund (BGB)  up $0.02. Banks were mixed. Our Trade of the Week made a morning move higher -- and then dropped to new daily lows. I added on the short side. Financial Select Sector SPDR Fund (XLF) up by $0.08. Insurance was very strong after a Lincoln National (LNC) beat (I remain small short). Hartford Financial (HIG) lacked this time. Brokerages are surprisingly strong, led by Goldman Sachs (GS) . Old tech down - with Comcast (CSCO) , Microsoft (MSFT) and Intel (INTC) lower. Retail still stinking up the joint with Nordstrom (JWN) , Target (TGT) , Foot Locker (FL) et al. notably weaker. I added to a poorly performing JC Penney (JCP) today. Awful sentiment in biotech, pharma and generic -- for obvious reasons. Biotech was a biowreck, breaking support levels. Allergan (AGN)  , Valeant Pharmaceuticals (VRX)  , Merck (MCK) etc lower. Speculative biotech like Sage Therapeutics (SAGE)  , Portula Pharmaceuticals (PTLA) ,  Acadia Pharmaceuticals (ACAD) , Aerie Pharmaceut
Investors rush to buy the drugmaker's stock following chatter of a much-needed megadeal.

Columnist Conversations

We added the Big Apple today as we see this breaking out on good turnover, strong institutional flow (option b...
Markets slightly up as we get closer to mid-day.  Oil barely holding $50 a barrel level as enthusiasm abo...
we'll roll DIS here and bank a win in COST SOLD DIS JAN 100 CALL AT 3.45 (in at 1.44) ...
The great Skip Raschke joins me after the close to talk options, trading and other stuff he has learned over a...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.